indazoles has been researched along with Hemangioblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asthagiri, AR; Chen, CJ; Ilyas, A; Mehta, GU; Oldfield, EH; Schiff, D; Taylor, DG | 1 |
| Dietrich, PY; Haller, S; Koka, A; Leemann, B; Merkler, D; Migliorini, D; Pugliesi-Rinaldi, A; Schaller, K | 1 |
| Jonasch, E; Kim, BY; McCutcheon, IE | 1 |
1 review(s) available for indazoles and Hemangioblastoma
| Article | Year |
|---|---|
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.
Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Cervical Vertebrae; Female; Follow-Up Studies; Hemangioblastoma; Humans; Indazoles; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2015 |
2 other study(ies) available for indazoles and Hemangioblastoma
| Article | Year |
|---|---|
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Indazoles; Kidney Neoplasms; Male; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2018 |
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
Topics: Cerebellar Neoplasms; Hemangioblastoma; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Sulfonamides; Treatment Outcome; von Hippel-Lindau Disease | 2012 |